Nimotop - Preparations for the improvement of blood circulation of the brain.
Nimotop has anti-ischemic effect, dilates blood vessels of the brain, prevents and relieves spasms of blood vessels of the brain, improves the stability of neurons. The active substance of Nimotop - nimodipine.
The drug has no effect on myocardial contraction and atrioventricular conduction, after its application due to the expansion of blood vessels, an increase of heart rate.
It is noted that use of the drug in patients with acute circulatory disorders of the brain helps to reduce the risk of ischemic neurological pathologies and reduce mortality rate.
Patients with impaired memory and attention after using Nimotop marked improvement in behavioral, indicators of psychometric testing.
Produce a solution for infusion and pill Nimotop.
Nimotop according to the instructions indicated for the treatment, prevention of ischemic neurological disturbances caused by spasms of cerebral vessels, or bleeding due to rupture of the aneurysm. For these indications prescribed pills or intravenous administration of the drug.
Nimotop tablets are used to treat disorders of concentration, memory loss, correction of psycho-emotional lability in elderly patients with severe cerebral pathology.
Nimotop of instructions is contraindicated in severe liver pathologies, severe hypotension, hypersensitivity to 18L children, lactating and pregnant women.
Nimotop can not be combined with phenytoin, carbamazepine, rifampicin, phenobarbital and other anti-epileptic drugs.
Because of the vital importance of Nimotop the only serious contraindication for intravenous infusion of the drug is the appearance of intolerance reactions funds.
Efficacy is reduced when combined with nefazodone and cimetidine and valproic acid increases the concentration of nimodipine in blood.
Instructions for use Nimotop
Nimotop tablets do not chew, between meals makes the interval between doses 4h.
When subarachnoid hemorrhage caused by rupture of the aneurysm through taking pills 5-14dn Nimotop infusion solution - 60 mg for 6 p / day. in a week.
According to the instructions Nimotop for the treatment of brain function in elderly patients take prescribed 30mg means three p / day. If a patient has impaired liver function, the dosage can be reduced.
For prevention of migraines take 30mg three p / day for several months.
To prevent the consequences of haemorrhage after 4 days after Nimotop infused intravenously. The duration of treatment - 10-14 days. Then go on the pill Nimotop - 6p 60 mg / day every four hours.
For the treatment of ischemic neurological arising because of subarachnoid hemorrhage, intravenous Nimotop over 5-14dn. Use of the drug, it is important to start as soon as possible after hemorrhage. At the end of the infusion therapy administered to a patient at a dosage of 60 mg tablet 6 / day every four hours.
A solution for infusion is susceptible to the effects of light, which is why during the procedure to avoid sunlight in an infusion pump, a solution piping.
Nimotop may cause diarrhea, nausea, indigestion, poor appetite, bloating, constipation, intestinal obstruction, dry mouth, dizziness, sleep disturbance, fatigue, aggressiveness, headache, tremor, depression, hyperactivity, thrombocytopenia, marked reduction of pressure, flushing, redness face, bradycardia, edema, tachycardia, rash, itching.
After intravenous infusion of Nimotop in its pure form may develop phlebitis.
In case of overdose means sharply reduced pressure having tachycardia and bradycardia.
Nimotop tablets in doses exceeding recommended, can cause vomiting, abdominal pain, disruption of the central nervous system.
Under reduced pressure injected norepinephrine or dopamine, and for poisoning pills appoint reception sorbents, washed stomach.